Paul Tudor Jones Sorrento Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $702,983 - $1.11 Million	-110,706 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $337,046 - $791,555	47,944 Added 76.39%	110,706 $916,000
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $361,509 - $750,005	62,762 New	62,762 $428,000
Q3 2020 Nov 16, 2020	SELL	$6.17 - $18.82 $170,804 - $520,994	-27,683 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $47,891 - $187,137	27,683 New	27,683 $174,000

Q1 2020 May 15, 2020	SELL	$1.57 - $4.76 $19,028 - $57,691	-12,120 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.45 - $4.17 $17,574 - $50,540	12,120 New	12,120 $41,000
Q2 2018 Aug 14, 2018	SELL	$4.75 - $8.0 $517,142 - $870,976	-108,872 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.5 - $9.95 $350,604 - $775,224	77,912 Added 251.65%	108,872 $561,000
Q4 2017 Feb 14, 2018	BUY	$1.75 - $3.8 $54,180 - $117,648	30,960	30,960 $118,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.